Condition

Hunter Syndrome

Treatments and trials tagged Hunter Syndrome. Filter by country, access level, or patient stories.

All countries United States Canada United Kingdom Japan China Australia Switzerland European Union Newest Patient Stories

FDA ApprovedUnited States

New Weekly Infusion for Children with Hunter Syndrome

Avlayah (tividenofusp alfa-eknm) for neurologic Hunter syndrome (MPS II)

FDA accelerated approval (24 March 2026 letter; press 25 March 2026) for Avlayah (tividenofusp alfa-eknm) — a once-weekly IV enzyme replacement for neurologic…

Avlayah is a weekly infusion for the brain effects of Hunter syndrome in children of at least 5 kilograms.

September 7, 2026